Get started
Author

Satoru Nihei

Observed names: Nihei, Satoru, S. Nihei, SATORU NIHEI, ニヘイ, サトル
ORCID: 0000-0003-3179-677X
Observed ORCID: 0000-0003-3179-677X
OpenAlex ID: A5035470630
The effectiveness of regional cooling for paclitaxel-induced peripheral neuropathy
2016 · Junya Sato, Megumi Mori, et al. · Journal of Pharmaceutical Health Care and Sciences · 38
PDF
High level of C-reactive protein as a predictive factor for immune-related adverse events of immune checkpoint inhibitors in non-small cell lung cancer: a retrospective study
2023 · Ren Onodera, Shinji Chiba, et al. · Journal of Thoracic Disease · 28
PDF
The efficacy of sodium azulene sulfonate L-glutamine for managing chemotherapy-induced oral mucositis in cancer patients: a prospective comparative study
2018 · Satoru Nihei, Junya Sato, et al. · Journal of Pharmaceutical Health Care and Sciences · 26
PDF
Antiproteinuric effects of renin–angiotensin inhibitors in lung cancer patients receiving bevacizumab
2018 · Satoru Nihei, Junya Sato, et al. · Cancer Chemotherapy and Pharmacology · 20
Objective evaluation of chemotherapy-induced peripheral neuropathy using quantitative pain measurement system (Pain Vision®), a pilot study
2017 · Junya Sato, Megumi Mori, et al. · Journal of Pharmaceutical Health Care and Sciences · 15
PDF
Effect of blood pressure control on the risk of proteinuria during bevacizumab treatment in patients with colorectal cancer: a single-center retrospective cohort study
2024 · Satoru Nihei, Junichi Asaka, et al. · Journal of Pharmaceutical Health Care and Sciences · 11
PDF
Effect of olanzapine for breast cancer patients resistant to triplet antiemetic therapy with nausea due to anthracycline-containing adjuvant chemotherapy
2016 · Junya Sato, Masahiro Kashiwaba, et al. · Japanese Journal of Clinical Oncology · 11
PDF
Field Survey of the Anticancer Drug Contamination in the Preparation Environment ～Usefulness of the 5-FU Monitoring by the Coupon Method～
2014 · Junya Sato, Megumi Mori, et al. · YAKUGAKU ZASSHI · 11
PDF
[Efficacy and safety of pregabalin for oxaliplatin- and paclitaxel-induced peripheral neuropathy].
2013 · Satoru Nihei, Junya Sato, et al. · PubMed · 10
Bevacizumab Increases Endothelin-1 Production via Forkhead Box Protein O1 in Human Glomerular Microvascular Endothelial Cells In Vitro
2021 · Satoru Nihei, Junichi Asaka, et al. · International Journal of Nephrology · 9
PDF
Analysis of risk factors for skin disorders caused by anti‐epidermal growth factor receptor antibody drugs and examination of methods for their avoidance
2021 · Hiroaki Takahashi, Junichi Asaka, et al. · Journal of Clinical Pharmacy and Therapeutics · 8
PDF
[The Effectiveness of Polaprezinc Preparation for Taste Alteration in Cancer Chemotherapy].
2016 · Yasuhiro Mizukami, Junya Sato, et al. · PubMed · 8
Case series on the association between blood levels and side effects of afatinib maleate
2017 · Junya Sato, Naoto Morikawa, et al. · Cancer Chemotherapy and Pharmacology · 7
Plasma endothelin-1 may predict bevacizumab-induced proteinuria in patients with colorectal cancer
2023 · Satoru Nihei, Tatsuki Ikeda, et al. · Cancer Chemotherapy and Pharmacology · 6
Feasibility study of short hydration using oral rehydration solution in cisplatin including chemotherapy of lung cancer
2016 · Junya Sato, Naoto Morikawa, et al. · Journal of Pharmaceutical Health Care and Sciences · 6
PDF
Severe proteinuria during the administration of bevacizumab plus mFOLFOX6 in a colorectal cancer patient after kidney transplantation: a case report
2020 · Ren Onodera, Satoru Nihei, et al. · Journal of Pharmaceutical Health Care and Sciences · 5
PDF
Potential role of endothelial dysfunction in hypertension and proteinuria in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab: a pilot prospective observational study
2025 · Satoru Nihei, Kazuki Saito, et al. · Cancer Chemotherapy and Pharmacology · 4
A Prospective Comparison of Azilsartan and Amlodipine for Bevacizumab-induced Hypertension and Proteinuria in Colorectal Cancer
2026 · SATORU NIHEI, HARUKI UJIIE, et al. · In Vivo · 3
PDF
Identifying risk factors for opioid-induced neurotoxicity in cancer patients receiving oxycodone
2023 · Takashi Omoto, Junichi Asaka, et al. · Supportive Care in Cancer · 3
Effect of risk factors for acneiform rash induced by anti-epidermal growth factor receptor antibody drugs on survival: a retrospective observational study
2022 · Hiroaki Takahashi, Yukiko Yaegashi, et al. · Journal of Pharmaceutical Health Care and Sciences · 3
PDF
Deterioration of Glycemic Control Contributes to the Prevalence of Proteinuria among Bevacizumab-Treated Cancer Patients with Type 2 Diabetes Mellitus
2018 · Takeshi Chiba, Satoru Nihei, et al. · Biological and Pharmaceutical Bulletin · 3
PDF
Timing of bone-modifying agents after bone metastasis diagnosis and time to first skeletal-related event: A systematic review and study-level correlation analysis
2025 · Junya Sato, Tatsuki Ikeda, et al. · Journal of Oncology Pharmacy Practice · 1
Usefulness and Issues of Hospital–Pharmacy Collaboration in Outpatient Cancer Chemotherapy: A Study Based on a Patient Questionnaire Survey
2025 · Kazuki Saito, Satoru Nihei, et al. · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) · 1
PDF
Adverse Reactions With VEGF Inhibitors in Combination With NSAIDs: Disproportionality Analysis Using JADRE and FAERS
2025 · KAZUKI SAITO, SATORU NIHEI, et al. · In Vivo · 1
PDF
Characteristics of Hypocalcemia-related Reports in the JADER Database: A Pharmacovigilance Study
2026 · TATSUKI IKEDA, SATORU NIHEI, et al. · In Vivo
Works count: 49
Citation count: 238
H-index: 9
I10-index: 9
Year
Topic
Type